Catalent signs agreement to buy Cook Pharmica for $950m

US-based company Cook Group has reached an agreement to divest its drug manufacturing division Cook Pharmica to Catalent for $950m.

Source: Pharmaceutical Technology - September 19, 2017 Category: Pharmaceuticals Source Type: news